Biodesix Affirms FY2026 Sales Guidance of $108.000M-$114.000M vs $110.996M Est
Biodesix (NASDAQ: BDSX ) affirms FY2026 sales outlook from $108.000 million-$114.000 million to $108.000 million-$114.000 million vs $110.996 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.